Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial Orchestration of Skin Fibrosis by a CD8+ T cell-Myofibroblast Axis.

bioRxiv : the preprint server for biology·2026

Same author

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma.

Science advances·2026

Same author

Local gene editing of fibroblasts in tumors reveals a new cancer-associated fibroblast state.

The Journal of experimental medicine·2026

Same author

Computational discovery of precision therapeutics for hidradenitis suppurativa.

bioRxiv : the preprint server for biology·2026

Same author

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

The Journal of investigative dermatology·2025

Same author

Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Search research articles

Related Experiment Video

Updated: May 24, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

Treating human autoimmunity: current practice and future prospects.

Michael D Rosenblum¹, Iris K Gratz, Jonathan S Paw

¹Department of Dermatology, University of California, San Francisco, San Francisco, CA 94115, USA. rosenblummd@derm.ucsf.edu

Science Translational Medicine

|March 17, 2012

Summary

Autoimmune diseases arise from immune system dysfunction. New therapies aim to rebalance immune cells, restoring self-tolerance and avoiding broad immunosuppression.

More Related Videos

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Related Experiment Videos

Last Updated: May 24, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Area of Science:

Immunology
Autoimmunity
Therapeutic Development

Background:

Autoimmune diseases occur when immune cells mistakenly attack the body's own tissues.
A critical factor in preventing autoimmunity is maintaining a balance between effector and regulatory immune functions.

Purpose of the Study:

To review recent advances in therapies for autoimmune diseases.
To discuss challenges in targeting these therapies effectively while avoiding general immunosuppression.

Main Methods:

Review of current literature on novel immunotherapies.
Analysis of strategies for restoring immune balance in autoimmune conditions.

Main Results:

Emerging therapies include costimulation blockade, regulatory T cell therapy, antigen-specific immunotherapy, and IL-2 pathway modulation.
These approaches aim to restore immune homeostasis rather than cause broad immunosuppression.

Conclusions:

Targeting immune balance offers a promising strategy for autoimmune disease treatment.
Overcoming challenges in patient-specific targeting and minimizing off-target effects is crucial for therapeutic success.